Drug Information

Drug General Information
Drug ID
D08XGI
Former ID
DNC004123
Drug Name
(1-Phenethyl-piperidin-4-yl)-phenyl-methanone
Drug Type
Small molecular drug
Indication Discovery agent Investigative [525963]
Formula
C20H23NO
Canonical SMILES
C1CN(CCC1C(=O)C2=CC=CC=C2)CCC3=CC=CC=C3
InChI
1S/C20H23NO/c22-20(18-9-5-2-6-10-18)19-12-15-21(16-13-19)14-11-17-7-3-1-4-8-17/h1-10,19H,11-16H2
InChIKey
GEFOLRNTTIQKBZ-UHFFFAOYSA-N
PubChem Compound ID
10379653
Target and Pathway
Target(s) 5-hydroxytryptamine 2A receptor Target Info Inhibitor [525963]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Serotonergic synapse
Inflammatory mediator regulation of TRP channels
PANTHER Pathway 5HT2 type receptor mediated signaling pathway
Reactome Serotonin receptors
G alpha (q) signalling events
WikiPathways Serotonin Receptor 2 and STAT3 Signaling
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
SIDS Susceptibility Pathways
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 525963J Med Chem. 2001 Feb 15;44(4):477-501.Current and novel approaches to the drug treatment of schizophrenia.
Ref 525963J Med Chem. 2001 Feb 15;44(4):477-501.Current and novel approaches to the drug treatment of schizophrenia.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.